BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 38 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,658,150 | +34.7% | 8,790,000 | +37.1% | 0.00% | 0.0% |
| Q2 2023 | $6,426,026 | +127.8% | 6,410,000 | +144.2% | 0.00% | – |
| Q4 2022 | $2,820,694 | +1832.0% | 2,625,000 | +1697.9% | 0.00% | – |
| Q3 2022 | $146,000 | +121.2% | 146,000 | +121.2% | 0.00% | – |
| Q2 2022 | $66,000 | -87.6% | 66,000 | -87.5% | 0.00% | – |
| Q1 2022 | $531,000 | -13.1% | 530,000 | -9.6% | 0.00% | – |
| Q4 2021 | $611,000 | +6.3% | 586,000 | +0.9% | 0.00% | – |
| Q3 2021 | $575,000 | +147.8% | 581,000 | +151.5% | 0.00% | – |
| Q2 2021 | $232,000 | – | 231,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVENT CAPITAL MANAGEMENT /DE/ | 70,652,000 | $71,212,000 | 1.38% |
| SHENKMAN CAPITAL MANAGEMENT INC | 14,821,000 | $14,947,000 | 1.36% |
| AQR Arbitrage LLC | 21,650,000 | $21,800,000 | 0.61% |
| Worth Venture Partners, LLC | 708,000 | $714,000 | 0.27% |
| LOOMIS SAYLES & CO L P | 2,366,716 | $197,478,000 | 0.24% |
| MACKAY SHIELDS LLC | 24,500,000 | $24,670,000 | 0.23% |
| CAMDEN ASSET MANAGEMENT L P /CA | 2,500,000 | $2,505,000 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,429,000 | $2,442,000 | 0.06% |
| Alberta Investment Management Corp | 5,500,000 | $5,545,000 | 0.05% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,900,000 | $1,913,000 | 0.04% |